U.S. Capital Wealth Advisors’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-137,655
Closed -$1.53M 1524
2022
Q4
$1.53M Sell
137,655
-103
-0.1% -$1.08K 0.07% 256
2022
Q3
$1.17M Sell
137,758
-273
-0.2% -$2.69K 0.06% 305
2022
Q2
$1.45M Sell
138,031
-34,881
-20% -$382K 0.06% 284
2022
Q1
$1.88M Sell
172,912
-133,483
-44% -$1.76M 0.07% 266
2021
Q4
$4.15M Buy
306,395
+67,296
+28% +$899K 0.16% 136
2021
Q3
$3.25M Buy
+239,099
New +$3.39M 0.14% 168

Other funds holding VTRS

U.S. Capital Wealth Advisors's VTRS Position: Q1 2023 in Review

U.S. Capital Wealth Advisors sold out of Viatris (VTRS) in Q1 2023, closing a stake of 137,655 shares — an estimated $1.53M sold.

U.S. Capital Wealth Advisors first reported a position in VTRS in Q3 2021 and held it in 6 quarters. The position peaked at $4.15M in Q4 2021. 988 funds tracked by Wall St. Rank hold VTRS as of Q1 2023.

  • U.S. Capital Wealth Advisors reported no remaining Viatris position as of Q1 2023 after selling out during the quarter.
  • U.S. Capital Wealth Advisors sold 137,655 Viatris shares in Q1 2023, an estimated $1.53M.
  • U.S. Capital Wealth Advisors first reported a position in Viatris in Q3 2021 and held it in 6 quarters.
  • U.S. Capital Wealth Advisors's Viatris position peaked at $4.15M in Q4 2021.
  • 988 funds tracked by Wall St. Rank held Viatris as of Q1 2023.

Based on U.S. Capital Wealth Advisors's 13F filing for Q1 2023, filed 11 May 2023.